Financial Ratios Jiangsu HHCK Advanced Materials Co., Ltd.
Equities
688535
CNE100006046
Specialty Chemicals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
80.00 CNY | -0.39% |
|
-1.72% | +7.60% |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.25 | 7.74 | 5.06 | 1.03 | 0.62 | |||||
Return on Total Capital | 11.68 | 11.8 | 7 | 1.22 | 0.7 | |||||
Return On Equity % | 27.43 | 20.84 | 11.41 | 4.5 | 3.86 | |||||
Return on Common Equity | 27.53 | 20.89 | 11.41 | 4.5 | 3.88 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.68 | 28.98 | 26.91 | 26.73 | 25.31 | |||||
SG&A Margin | 9.28 | 7.88 | 8.09 | 12.07 | 12.57 | |||||
EBITDA Margin % | 16.33 | 17.54 | 16.82 | 9.11 | 9.19 | |||||
EBITA Margin % | 13.83 | 14.88 | 13.46 | 5.19 | 4.15 | |||||
EBIT Margin % | 13.71 | 14.79 | 13.37 | 5.04 | 3.96 | |||||
Income From Continuing Operations Margin % | 11.13 | 13.75 | 13.6 | 11.18 | 12.04 | |||||
Net Income Margin % | 10.94 | 13.71 | 13.6 | 11.18 | 12.08 | |||||
Net Avail. For Common Margin % | 10.94 | 13.71 | 13.6 | 11.18 | 12.08 | |||||
Normalized Net Income Margin | 7.27 | 8.52 | 8.45 | 6.34 | 7.08 | |||||
Levered Free Cash Flow Margin | -1.83 | -2.26 | 8.2 | -22.98 | -16.83 | |||||
Unlevered Free Cash Flow Margin | -0.76 | -1.53 | 8.2 | -22.82 | -16.46 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.85 | 0.84 | 0.61 | 0.33 | 0.25 | |||||
Fixed Assets Turnover | 3.77 | 3.98 | 2.56 | 1.72 | 1.51 | |||||
Receivables Turnover (Average Receivables) | 1.54 | 1.68 | 1.47 | 1.46 | 1.62 | |||||
Inventory Turnover (Average Inventory) | 5.08 | 4.74 | 3.27 | 2.84 | 3.05 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.14 | 2.67 | 2.98 | 1.86 | 1.87 | |||||
Quick Ratio | 0.96 | 2.18 | 2.35 | 1.32 | 1.43 | |||||
Operating Cash Flow to Current Liabilities | -0.03 | 0.01 | 0.1 | 0.18 | 0.02 | |||||
Days Sales Outstanding (Average Receivables) | 237.07 | 216.83 | 248.38 | 250.24 | 226.03 | |||||
Days Outstanding Inventory (Average Inventory) | 72.03 | 76.98 | 111.47 | 128.64 | 120.09 | |||||
Average Days Payable Outstanding | 101.81 | 78.81 | 104.49 | 108.27 | 94.09 | |||||
Cash Conversion Cycle (Average Days) | 207.29 | 215 | 255.36 | 270.61 | 252.02 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 74.35 | 0.32 | - | 5.07 | 20.3 | |||||
Total Debt / Total Capital | 42.64 | 0.32 | - | 4.83 | 16.87 | |||||
LT Debt/Equity | - | - | - | - | 13.6 | |||||
Long-Term Debt / Total Capital | - | - | - | - | 11.31 | |||||
Total Liabilities / Total Assets | 65.71 | 30.77 | 25.09 | 16.51 | 25.9 | |||||
EBIT / Interest Expense | 7.96 | 12.7 | 1.04K | 19.65 | 6.68 | |||||
EBITDA / Interest Expense | 9.48 | 15.06 | 1.31K | 35.52 | 15.52 | |||||
(EBITDA - Capex) / Interest Expense | 8.23 | 12.78 | 1.06K | -62.99 | -18.17 | |||||
Total Debt / EBITDA | 2.1 | 0.02 | - | 2.02 | 6.92 | |||||
Net Debt / EBITDA | 1.99 | -1.46 | -1.59 | 0.61 | 5.08 | |||||
Total Debt / (EBITDA - Capex) | 2.42 | 0.02 | - | -1.14 | -5.91 | |||||
Net Debt / (EBITDA - Capex) | 2.29 | -1.72 | -1.96 | -0.34 | -4.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 43.84 | 40.2 | -12.67 | -6.7 | 17.23 | |||||
Gross Profit, 1 Yr. Growth % | 48.73 | 32.44 | -18.91 | -7.3 | 10.98 | |||||
EBITDA, 1 Yr. Growth % | 226.94 | 50.62 | -16.26 | -44.57 | 17.8 | |||||
EBITA, 1 Yr. Growth % | 417.38 | 50.81 | -20.95 | -59.58 | -6.95 | |||||
EBIT, 1 Yr. Growth % | 433.48 | 51.24 | -21.07 | -60.32 | -7.87 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 545.19 | 73.07 | -13.62 | -23.26 | 26.22 | |||||
Net Income, 1 Yr. Growth % | 563.22 | 75.62 | -13.39 | -23.26 | 26.63 | |||||
Normalized Net Income, 1 Yr. Growth % | 8.3K | 64.32 | -13.44 | -21.13 | 30.95 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 562.85 | 53.5 | -29.68 | -38.24 | 19.05 | |||||
Accounts Receivable, 1 Yr. Growth % | 51.44 | 13.14 | -11.86 | -0.73 | 13.88 | |||||
Inventory, 1 Yr. Growth % | 7.98 | 96.45 | -3.59 | 19.86 | 4.07 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 40.15 | 27.38 | 41.77 | 36.87 | 32.06 | |||||
Total Assets, 1 Yr. Growth % | 32.31 | 48.91 | 1.87 | 143.32 | 13.99 | |||||
Tangible Book Value, 1 Yr. Growth % | 37.56 | 234.72 | 10.71 | 172.25 | 1.25 | |||||
Common Equity, 1 Yr. Growth % | 31.93 | 206.84 | 10.24 | 171.17 | 1.15 | |||||
Cash From Operations, 1 Yr. Growth % | -158.94 | -126.55 | 607.75 | 164.41 | -90.58 | |||||
Capital Expenditures, 1 Yr. Growth % | -3.85 | 73.2 | 5.52 | 634.35 | -7.37 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -206.58 | 72.86 | -416.75 | -397.94 | -14.13 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -126.3 | 183.97 | -567.74 | -395.54 | -15.43 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 0 | 100 | 50 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 35.94 | 42.01 | 10.65 | -9.73 | 4.58 | |||||
Gross Profit, 2 Yr. CAGR % | 51.22 | 40.35 | 3.63 | -13.3 | 1.43 | |||||
EBITDA, 2 Yr. CAGR % | 107.08 | 121.91 | 12.3 | -34.95 | -19.02 | |||||
EBITA, 2 Yr. CAGR % | 174.48 | 179.33 | 9.19 | -46.68 | -38.44 | |||||
EBIT, 2 Yr. CAGR % | 181.08 | 184.05 | 9.26 | -47.32 | -39.54 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 243.35 | 234.16 | 22.27 | -18.58 | -1.58 | |||||
Net Income, 2 Yr. CAGR % | 240.41 | 241.28 | 23.33 | -18.47 | -1.42 | |||||
Normalized Net Income, 2 Yr. CAGR % | 440.22 | 1.07K | 19.26 | -22.15 | 1.62 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 254.96 | 218.98 | 3.89 | -34.1 | -14.25 | |||||
Accounts Receivable, 2 Yr. CAGR % | 42.64 | 30.9 | -0.14 | -6.46 | 6.32 | |||||
Inventory, 2 Yr. CAGR % | 9.79 | 45.65 | 37.62 | 7.5 | 11.69 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 24.19 | 33.61 | 34.39 | 39.3 | 34.44 | |||||
Total Assets, 2 Yr. CAGR % | 27.07 | 40.37 | 23.17 | 57.44 | 66.54 | |||||
Tangible Book Value, 2 Yr. CAGR % | 27.19 | 114.57 | 92.5 | 73.61 | 66.03 | |||||
Common Equity, 2 Yr. CAGR % | 28.17 | 101.2 | 83.91 | 72.89 | 65.61 | |||||
Cash From Operations, 2 Yr. CAGR % | -5.23 | -60.44 | 37.08 | 332.59 | -50.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | 57.98 | 29.05 | 35.19 | 178.36 | 160.81 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 44.46 | 35.73 | 133.99 | 187.83 | 59.96 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 164.76 | -13.58 | 264.45 | 248.37 | 58.1 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | 41.42 | 73.21 | 22.47 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 22.99 | 37.34 | 20.76 | 4.54 | -1.52 | |||||
Gross Profit, 3 Yr. CAGR % | 21.03 | 44.68 | 16.89 | -0.15 | -5.86 | |||||
EBITDA, 3 Yr. CAGR % | 29.57 | 86.23 | 60.36 | -13.94 | -20.59 | |||||
EBITA, 3 Yr. CAGR % | 34.01 | 124.81 | 83.39 | -24.6 | -35.65 | |||||
EBIT, 3 Yr. CAGR % | 34.42 | 128.62 | 85.36 | -25.13 | -36.53 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 36.67 | 173.25 | 112.87 | 4.69 | -5.77 | |||||
Net Income, 3 Yr. CAGR % | 35.89 | 173.01 | 116.07 | 5.29 | -5.58 | |||||
Normalized Net Income, 3 Yr. CAGR % | 39.22 | 263.31 | 392.47 | -0.13 | -7.41 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 36.08 | 168.43 | 92.69 | -12.64 | -19.74 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.21 | 32.04 | 14.73 | -0.34 | -0.12 | |||||
Inventory, 3 Yr. CAGR % | 8.11 | 33.29 | 26.93 | 31.43 | 6.34 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.83 | 25.24 | 36.28 | 35.21 | 36.84 | |||||
Total Assets, 3 Yr. CAGR % | 20.61 | 33.97 | 26.14 | 54.54 | 41.37 | |||||
Tangible Book Value, 3 Yr. CAGR % | 19.09 | 75.6 | 72.1 | 116.08 | 45.05 | |||||
Common Equity, 3 Yr. CAGR % | 19.38 | 71.46 | 64.64 | 109.33 | 44.6 | |||||
Cash From Operations, 3 Yr. CAGR % | -4.53 | -37.99 | 3.46 | 70.63 | 20.79 | |||||
Capital Expenditures, 3 Yr. CAGR % | 55.46 | 62.9 | 20.67 | 137.64 | 92.89 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -29.25 | 53.36 | 80.04 | 142.84 | 92.33 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -44.24 | 171.02 | 51.73 | 225.42 | 117.32 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | 44.22 | 44.22 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 22.17 | 25.24 | 17.9 | 16.12 | 14.01 | |||||
Gross Profit, 5 Yr. CAGR % | 22.03 | 20.99 | 13.74 | 17.88 | 10.44 | |||||
EBITDA, 5 Yr. CAGR % | 36.83 | 29.29 | 22.36 | 22.28 | 19.78 | |||||
EBITA, 5 Yr. CAGR % | 54.21 | 32.52 | 23.47 | 26.43 | 15.77 | |||||
EBIT, 5 Yr. CAGR % | 55.99 | 32.91 | 23.73 | 27.09 | 15.58 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 91.82 | 40.13 | 30.72 | 68.36 | 56.35 | |||||
Net Income, 5 Yr. CAGR % | 91.16 | 40.06 | 30.72 | 68.36 | 57.86 | |||||
Normalized Net Income, 5 Yr. CAGR % | 87.39 | 33.68 | 30.87 | 96.19 | 155.8 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 99.37 | 41.58 | 22.16 | 53.06 | 39.38 | |||||
Accounts Receivable, 5 Yr. CAGR % | 30.69 | 26.4 | 15.47 | 15.03 | 11.29 | |||||
Inventory, 5 Yr. CAGR % | 14.34 | 27.9 | 19.07 | 22.3 | 20.6 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.93 | 13.36 | 22.28 | 30.69 | 35.54 | |||||
Total Assets, 5 Yr. CAGR % | 19.13 | 26.44 | 21.62 | 42.91 | 40.97 | |||||
Tangible Book Value, 5 Yr. CAGR % | 20.82 | 47.45 | 44.31 | 74.8 | 69.64 | |||||
Common Equity, 5 Yr. CAGR % | 19.37 | 44.24 | 41.9 | 72.03 | 65.03 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.19 | -5.33 | 10.34 | 34.87 | -22.71 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.89 | 43.32 | 47.01 | 101.83 | 64.24 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -25.85 | -7.95 | 14.16 | 97.28 | 67.3 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -36.61 | -11.67 | 18.16 | 199.65 | 50.28 |
Select your edition
All financial news and data tailored to specific country editions